---
title: "Find Funding Sources for LHON Research"
description: "Compile a comprehensive database of active funding opportunities for LHON and mitochondrial disease research worldwide."
category: "Funding"
difficulty: "moderate"
status: "open"
prize: null
icon: "ðŸ’°"
order: 1
successCriteria:
  - "Identify at least 10 active funding sources"
  - "Each entry includes: organization name, program name, URL, deadline, amount range, eligibility requirements"
  - "Sources span government grants, private foundations, and pharmaceutical programs"
  - "Include rare disease-specific funding mechanisms (orphan drug designations, etc.)"
  - "Results formatted as structured JSON and human-readable markdown"
resources:
  - name: "NIH Reporter - Grant Database"
    url: "https://reporter.nih.gov/"
  - name: "UMDF Research Grants"
    url: "https://umdf.org/research/"
  - name: "EU Horizon Europe"
    url: "https://ec.europa.eu/info/funding-tenders/"
  - name: "ClinicalTrials.gov"
    url: "https://clinicaltrials.gov/search?cond=LHON"
  - name: "Orphanet - Rare Disease Portal"
    url: "https://www.orpha.net/"
---

## Background

Research funding is the lifeblood of medical breakthroughs. LHON, as a rare disease affecting approximately 1 in 15,000-50,000 people, faces unique funding challenges. While organizations like the United Mitochondrial Disease Foundation (UMDF) have provided over $15 million in research funding, and advocacy has secured $55 million in federal funding, many funding opportunities remain undiscovered or underutilized.

## What Needs to Be Done

Create a comprehensive, structured database of all active funding opportunities available for LHON and related mitochondrial disease research. This includes:

1. **Government grants** - NIH (USA), EU Horizon Europe, national research councils worldwide
2. **Private foundations** - UMDF, LHON Society, Vision Hope Now, Knights Templar Eye Foundation
3. **Pharmaceutical programs** - Companies developing LHON therapeutics (Chiesi, GenSight Biologics, Neurophth)
4. **Rare disease mechanisms** - Orphan drug designations, rare disease research incentives
5. **International sources** - Research councils in UK, Australia, Japan, South Korea, and other active LHON research regions

## Why This Matters

Researchers often miss funding opportunities simply because they don't know they exist. A comprehensive, up-to-date funding database could directly accelerate LHON research by connecting researchers with the resources they need.

## How to Submit

Submit your results by opening a GitHub issue with the label `find-funding`. Include your structured data and sources consulted.
